Back to ALNY
KBC Group NV ALNY Position History
Alnylam Pharmaceuticals, Inc. • Healthcare
Quarters held
14
Latest value
$74K
Q3 2026
Peak value
$135.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $30K |
| Q3 2025 | $121.9M |
| Q3 2025 | $2.7M |
| Q4 2025 | $26K |
| Q4 2025 | $135.5M |
| Q4 2025 | $2.9M |
| Q1 2026 | $22K |
| Q1 2026 | $6.7M |
| Q1 2026 | $61K |
| Q2 2026 | $20K |
| Q2 2026 | $6M |
| Q2 2026 | $99K |
| Q3 2026 | $5.2M |
| Q3 2026 | $74K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $74K | 300 | — | — |
| Q3 2026 | $5.2M | 20.9K | — | — |
| Q2 2026 | $99K | 330 | — | — |
| Q2 2026 | $6M | 20.0K | — | — |
| Q2 2026 | $20K | 66 | — | — |
| Q1 2026 | $61K | 185 | — | — |
| Q1 2026 | $6.7M | 20.3K | — | — |
| Q1 2026 | $22K | 66 | — | — |
| Q4 2025 | $2.9M | 7.3K | — | — |
| Q4 2025 | $135.5M | 340.8K | — | — |
| Q4 2025 | $26K | 66 | — | — |
| Q3 2025 | $2.7M | 5.9K | — | — |
| Q3 2025 | $121.9M | 267.4K | — | — |
| Q3 2025 | $30K | 66 | — | — |
Other funds holding ALNY
$5.7B
$4.9B
$4.2B
$3.4B
$1.8B
$1.8B
$1.6B
$1.6B